CommonGround Can Help with Treatment Adherence

In the U.S., $32.5 billion dollars a year is spent on treatment of schizophrenia alone, with the bulk of those dollars spent on hospital care due to significant rates of medication nonadherence(1). CommonGround may increase treatment adherence because it helps people express and work through concerns about prescribed treatment upstream, before non-adherence becomes a problem.

As of September 2010, most people using CommonGround have indicated concerns about using prescribed medicine. Specifically, at first usage of the CommonGround Health Report, they reported on average 3 concerns for using prescribed medicine. The top 3 reported concerns were side effects, health concerns and concerns that the medicine is unhelpful.

In addition to flagging these concerns, CommonGround recommends strategies to resolve decisional uncertainty about using medicine as prescribed. In this way, CommonGround empowers doctors, therapists and case managers with the tools to engage clients about their concerns upstream before non-adherence becomes a problem.

Prescriber: "And somebody that's not taken their medicine in the past, you know, we’ve been able to spend maybe two or three minutes of the session talking about why they’re not taking the medicines and getting their pros and cons and kind of just that real brief snapshot in time of whether they want to take meds or not, but now we can send them home and they do a couple of different worksheets or maybe a calendar over the month to see how things are working and get, I think, a much broader and more accurate picture and make probably a much better decision on why they would or wouldn’t want to take meds."

Previous Benefit

See the Next Benefit… Next Benefit